Showing results (951-960 of 5,723) with videos related to
Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|June 3, 2016
The role of IL-37 in cancerVivi A Ding, Ziwen Zhu, Huaping Xiao, et al.Medical Oncology (Northwood, London, England)|May 8, 2016
ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes?Michał Pędziwiatr, Magdalena Pisarska, Michał Kisielewski, et al.Medical Oncology (Northwood, London, England)|December 7, 2017
Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patientsGiuseppe Carlo Iorio, Pierfrancesco Franco, Elena Gallio, et al.Medical Oncology (Northwood, London, England)|December 7, 2017
Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatmentGabriela R Passos, Juliana A Camargo, Karen L Ferrari, et al.Medical Oncology (Northwood, London, England)|December 8, 2017
Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitorsDorota Ciołczyk-Wierzbicka, Dorota Gil, Piotr LaidlerMedical Oncology (Northwood, London, England)|November 2, 2017
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTeppei Matsumoto, Shingo Hatakeyama, Teppei Ookubo, et al.Medical Oncology (Northwood, London, England)|November 3, 2017
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2Cristina Meazza, Graziella Cefalo, Maura Massimino, et al.Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.Medical Oncology (Northwood, London, England)|September 3, 2017
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancerHeather Katz, Emnet Wassie, Mohamed AlsharediMedical Oncology (Northwood, London, England)|June 29, 2016
Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinomaJureeporn Chuerduangphui, Chamsai Pientong, Ponlatham Chaiyarit, et al.Pageof 573